F048 What’s New In Nail Management
DESCRIPTION
This session will highlight an update of common nail problems and their management by world renown nail experts. Updates on onychomycosis stewardship and emergence of treatment resistant strains, neoplasms, surgery pearls, psoriasis, nail research with practical implications, nail histopathology, simple chronic paronychia, onycholysis and the disappearing nail bed, and pediatric cases will be presented. This session is directed to Clinicians, Academicians, and Residents.
LEARNING OBJECTIVES
Discuss and recognize the diagnosis, worldwide changing epidemiology, management of onychomycosis and emerging resistance in pediatric and non-pediatric nail disorders.
Recognize and discuss nail neoplasms including warts and nail surgery pearls.
Recognize and discuss nail psoriasis, lichen planus, and chronic simple paronychia, onycholysis, "The Disappearing Nail Bed", latest research and advancements in nail dermatopathology.
SCHEDULE
9:01 AM
Update:Onychomycosis Epidemiology, Diagnosis, Topical Therapy
Shari Lipner, MD, PhD, FAAD
9:09 AM
Update:Dermatophyte Management Stewardship,Emerging Dermatophyte Resistance and New Systemic Treatments
Boni E. Elewski, MD, FAAD
9:18 AM
Update: What is New In Nail Research with Practical Implications
Dong-Youn Lee, MD, PhD, IFAAD
9:27 AM
Update:Intralesional Injections for Nail Disorders
9:36 AM
Update: Useful Surgical Pearls
Nathaniel J. Jellinek, MD, FAAD
9:45 AM
Update: What is New with Nail Tumors
Judith Dominguez-Cherit, MD
9:54 AM
Update: Managing Nail Warts
Nilton Gioia Di Chiacchio, MD, PhD
10:03 AM
Update:What is New in Nail Dermatopathology
Beth S. Ruben, MD, FAAD
10:08 AM
Update:What is New in Nail Dermatopathology
Adam Rubin, MD, FAAD
10:13 AM
Update:Diagnosis and Management of Nail Psoriasis
Dimitris Rigopoulos, MD, IFAAD
10:22 AM
Update:Diagnosis and Management of Nail Lichen Planus
Matilde Iorizzo, PhD, MD, IFAAD
10:31 AM
Update:Simple Chronic Paronychia and Simple Onycholysis and the Disappearing Nail Bed
Avner Shemer, MD, IFAAD
10:40 AM
Update:Recognition and Management of Selected Pediatric Nail Disorders
Jane S. Bellet, MD, FAAD
DIRECTOR
C. Ralph Daniel, MD, FAAD
SPEAKERS
Jane S. Bellet, MD, FAAD
Judith Dominguez-Cherit, MD
Boni E. Elewski, MD, FAAD
Nilton Gioia Di Chiacchio, MD, PhD
Matilde Iorizzo, PhD, MD, IFAAD
Nathaniel J. Jellinek, MD, FAAD
Dong-Youn Lee, MD, PhD, IFAAD
Shari Lipner, MD, PhD, FAAD
Dimitris Rigopoulos, MD, IFAAD
Beth S. Ruben, MD, FAAD
Adam Rubin, MD, FAAD
Avner Shemer, MD, IFAAD
HANDOUTS
DISCLOSURES
Jane S. Bellet, MD, FAAD
Maui Derm – Speaker(Honoraria); Merck & Co., Inc. – Stockholder(No Compensation Received); NobelPharma – Consultant (1099 relationship)(Honoraria);
C. Ralph Daniel, MD, FAAD
Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Medimetriks Pharmaceuticals, Inc. – Advisory Board(Stock Options); Ortho Dermatologics – Advisory Board(Honoraria); Springer Science & Business Media – Other(Fees); Visiting Professor – Speaker(Honoraria);
Judith Dominguez-Cherit, MD
No financial relationships exist with ineligible companies.
Boni E. Elewski, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); AnaptysBio – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); InflaRx GmbH – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding); Valeant Pharmaceuticals International – Consultant(Honoraria); Valeant Pharmaceuticals North America LLC – Investigator(Grants/Research Funding); Vanda Pharmaceuticals Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);
Nilton Gioia Di Chiacchio, MD, PhD
No financial relationships exist with ineligible companies.
Matilde Iorizzo, PhD, MD, IFAAD
No financial relationships exist with ineligible companies.
Nathaniel J. Jellinek, MD, FAAD
No financial relationships exist with ineligible companies.
Dong-Youn Lee, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Shari Lipner, MD, PhD, FAAD
BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);
Dimitris Rigopoulos, MD, IFAAD
No financial relationships exist with ineligible companies.
Beth S. Ruben, MD, FAAD
No financial relationships exist with ineligible companies.
Adam Rubin, MD, FAAD
Lippincott Wiliams & Wilkins – Other(Other Financial Benefit); New York University Langone Medical Center – Employee – Lab does not sell products(Salary); Springer Publishing – Other(Other Financial Benefit);
Avner Shemer, MD, IFAAD
AbbVie – Speaker/Faculty Education(Fees); AMI Technologies – Consultant(Fees); Eli Lilly and Company – Speaker/Faculty Education(Fees); Ex-It Medical Devices Limited – Consultant(Fees); GlaxoSmithKline – Speaker/Faculty Education(Fees); Janssen Biotech – Speaker/Faculty Education(Fees); NeoPharm Israel – Consultant(Fees); Novartis – Speaker/Faculty Education(Fees); Perrigo Company – Speaker/Faculty Education(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Sanofi – Speaker/Faculty Education(Equipment);